Форма документа : Стаття із журналу Шифр видання : Автор(и) : Ternovoy D. S., Bolbol Emirhan Oguzhan, Shevchenko A. Назва : Effectiveness of the use of the anti-virus drug in children with COVID - 19 Місце публікування : Український науково-медичний молодіжний журнал. - 2022. - № 1 спецвип. . - С. 19 (Шифр УУ14/2022/1 спецвип.) Предметні рубрики: Гроприносин-- тер прим MeSH-головна: ДЕТИ -- CHILD КОРОНАВИРУС -- CORONAVIRUS ПАНДЕМИИ -- PANDEMICS ИММУННАЯ СИСТЕМА -- IMMUNE SYSTEM ЛЕКАРСТВ ИСПОЛЬЗОВАНИЯ КОНТРОЛЬ -- DRUG UTILIZATION REVIEW Анотація: The first mention of coronavirus infection (COVID - 19) detected in Wuhan, China in 2019. Mankind has repeatedly suffered from epidemics. 2019 - 2021 is referred to as pandemic, called COVID - 19. COVID-19 is a modern virus that is associated with the same family of viruses as acute respiratory viral infection (ARI). In most cases, the disease in children is innocuous. In general, children are hospitalized due to the high risk of complications of viral pneumonia. The state of health of children and humanity in this infection is generally characterized by a decrease in immunological reactivity, especially in acute respiratory viral infections such as COVID-19. The purpose of the work The aim of this study was to determine the effect of the drug “GROPRINOSIN” on the course of coronavirus infection in children and its specificity in relation to cells involved in immune processes Дод.точки доступу: Bolbol, Emirhan Oguzhan Shevchenko, A.